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Introduction
Ionizing radiation is a known risk factor for 
cancer [United Nations Scientific Committee 
on the Effects  of  Atomic Radiat ion 
(UNSCEAR) 2006]. For a given radiation 
dose, children are at a greater risk than adults 
(UNSCEAR 2013). Ionizing radiation is the 
only established environmental risk factor 
for childhood leukemia and tumors of the 
central nervous system (CNS), the two most 
common tumor types in childhood (Belson 
et al. 2007; Wiemels 2012; Wrensch et al. 
2002). Evidence for the carcinogenic effects 
of ionizing radiation in children comes 
mainly from studies of exposure to moderate 
or high doses from atomic bombs or thera-
peutic radiation (Wakeford 2013; Wrensch 
et al. 2002). It remains unclear whether 
dose–response relationships observed in these 
study populations extend to lower doses from 
more widespread exposures such as diagnostic 
radiology or natural background radiation 
(Wakeford 2013).
Natural background radiation is ubiqui-
tous and, for most people, the main source of 
radiation exposure (UNSCEAR 2000). About 
a third of this is attributable to cosmic rays 
and terrestrial gamma radiation whereas the 
rest is due to inhalation (mainly indoor radon) 
and ingestion of radionuclides (UNSCEAR 
2000). Whereas the effective dose from radon 
is delivered primarily to the respiratory system, 
terrestrial gamma and cosmic rays dominate 
doses to the red bone marrow (Kendall et al. 
2009), the primary site of leukemia initia-
tion. In Switzerland, exposure levels of the 
resident population to background radiation 
vary considerably due to the relatively high 
radioactivity of crystalline rocks of the central 
Alpine massif compared with the sedimen-
tary northern Alpine Foreland (Jura, Molasse 
Basin) (Rybach et al. 1996, 2002).
Most previous studies on the risk of 
childhood cancer and background ionizing 
radiation from terrestrial gamma or cosmic 
rays were ecological. Results from these 
studies were heterogeneous. Most of them 
showed little or no evidence of an associa-
tion (Auvinen et al. 1994; Evrard et al. 2006; 
Mason and Miller 1974; Muirhead et al. 
1992; Richardson et al. 1995; Tirmarche et al. 
1988), and others suggested a positive (Hatch 
and Susser 1990; Knox et al. 1988) or even 
a negative association (Frigerio et al. 1973). 
Few studies to date have used individual data 
(Axelson et al. 2002; Kendall et al. 2013; 
UK Childhood Cancer Study Investigators 
2002b). A case–control study from the 
United Kingdom using measurements made 
in children’s homes found no evidence of an 
association (UK Childhood Cancer Study 
Investigators 2002b). Recently, a record-
based case–control study from the United 
Kingdom found evidence of an increasing risk 
with cumulative gamma-ray dose for child-
hood leukemia but not for other cancer types 
(Kendall et al. 2013).
Given the limited and conflicting evidence 
from previous studies, we used a nationwide 
cohort study to investigate the association 
between external ionizing radiation from 
cosmic and terrestrial sources and incidence 
of childhood cancer and its major diagnostic 
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included. The follow-up period lasted until 2008, and incident cancer cases were identified from the 
Swiss Childhood Cancer Registry. A radiation model was used to predict dose rates from terrestrial 
and cosmic radiation at locations of residence. Cox regression models were used to assess associa-
tions between cancer risk and dose rates and cumulative dose since birth.
results: Among 2,093,660 children included at census, 1,782 incident cases of cancer were 
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Adjustment for a range of potential confounders had little effect on the results.
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groups in Switzerland. Geocoded residential 
locations at census time points were available 
for the entire population, and a spatial model 
with separate components for terrestrial gamma 
radiation and the directly ionizing component 
of cosmic radiation was used for exposure 
assessment. Cases were identified from the 
Swiss Childhood Cancer Registry (SCCR; 
http://www.childhoodcancerregistry.ch/) 
(Michel et al. 2008).
Methods
Population. Our study included the Swiss 
resident population < 16 years of age. Data 
collected on these children during national 
censuses in 1990 and 2000, including geore-
ferenced residential locations and demo-
graphic and socioeconomic information, were 
obtained from the Swiss National Cohort 
(SNC; http://www.swissnationalcohort.ch/) 
(Bopp et al. 2009). The SNC is a research 
platform based on nationwide individual 
record linkage between different censuses and 
mortality and migration records. This linkage 
allows calculating follow-up time for all indi-
viduals registered in the two censuses (Bopp 
et al. 2009; Spoerri et al. 2010). Birth weight 
and birth order were obtained through record 
linkage with the national birth registry. We 
excluded children whose residential locations 
were unknown or uncertain or could not be 
georeferenced to within 100 m.
Cases of childhood cancer were identified 
from the SCCR. The SCCR has an estimated 
completeness of > 90% for cancers in children 
< 16 years old diagnosed in Switzerland since 
1985 (Michel et al. 2008). We included all 
cases with a tumor classified according to 
the International Classification of Childhood 
Cancer, Third Edition (ICCC-3; http://seer.
cancer.gov/iccc/) (Steliarova-Foucher et al. 
2005). The SCCR collects residential address 
histories of patients from diagnosis back 
to birth, allowing us to obtain residence at 
census. Addresses were geocoded using a list 
of georeferenced building addresses from the 
Swiss postal system (GeoPost) or manually 
using the geoportal maintained by the Federal 
Office of Topography (swisstopo) at http://
map.geo.admin.ch. We used probabilistic 
record linkage (G-LINK 2.3; Statistics 
Canada; http://www5.statcan.gc.ca/olc-cel/
olc.action?lang=en&ObjId=10H0036&Ob
jType=22) to link cases with children from 
the SNC based on the variables sex, date of 
birth, maternal and paternal dates of birth, 
geocoded residence at census, municipality of 
residence at census and at birth, and nation-
ality. This study is based on register data, and 
informed consent was not required. The SNC 
was approved by the ethics committees of 
the Cantons of Bern and Zurich and by the 
Federal Data Protection Office (http://www.
edoeb.admin.ch/?lang=en).
Outcomes. We limited analyses to major 
diagnostic categories: any cancer (all ICCC-3 
diagnostic groups), leukemias (ICCC-3 diag-
nostic group I), acute lymphoblastic leukemias 
(ALL) (I.a), lymphomas (II), and tumors of 
the CNS tumors (III), which include malig-
nant and nonmalignant intracranial and 
intraspinal tumors. We also analyzed other 
malignant tumors comprising all remaining 
ICCC-3 diagnostic groups (IV–XII).
Exposure assessment. We estimated 
exposure to external background radiation 
as total dose rates at children’s homes from 
cosmic and terrestrial sources based on a previ-
ously developed exposure model (Rybach et al. 
1996, 2002). This model estimates total dose 
rates for each cell of a 2 km × 2 km grid as the 
sum of three separately estimated components: 
the directly ionizing component of cosmic 
radiation, natural terrestrial gamma radia-
tion, and artificial terrestrial radiation. The 
cosmic dose rate is calculated as a function of 
altitude. Grid values were obtained by aver-
aging topographic altitude within grid cells 
using a digital terrain model. The natural 
terrestrial component combines airborne 
gamma-ray spectrometry (about 10% of the 
country’s surface surveyed by helicopter), 
in situ gamma-ray spectrometry (166 sites), 
in situ dose rate measurements using ioniza-
tion chambers (837 sites), and laboratory 
measurements of rock and soil samples from 
612 sites. These measurements span the time 
period from the early 1960s to mid-1990s. In 
addition to airborne measurements, a total of 
1,615 ground data points were available; these 
correspond to about 1 point per 25 km2. The 
model did not account for temporal variations 
in natural radiation, for example, due to snow 
cover or sun activity. The artificial terrestrial 
component mainly reflects 137Cs (cesium) 
deposition originating from the Chernobyl 
accident and is based on airborne and in situ 
measurements taken after 1987. Grid cell 
dose rates for the terrestrial components were 
interpolated from the available data points 
using the inverse distance method and a search 
radius of 12 km. More details on measure-
ments and calibration procedures are provided 
elsewhere (Rybach et al. 1996).
Potential confounders. We considered 
the following potential confounding factors: 
traffic-related air pollution (proxied by distance 
to nearest highway), electromagnetic fields 
from radio and TV transmitters (field strength 
based on a geographic model) (Hauri et al. 
2014), and from high-voltage power lines 
(distance to nearest 380 kV or 220 kV power 
line), degree of urbanization of municipality 
(urban, peri-urban, rural), socioeconomic 
status based on the Swiss neighborhood 
index of socioeconomic position (Swiss-SEP) 
(Panczak et al. 2012), education of household 
reference person (compulsory, secondary, 
tertiary), and crowding (number of persons 
per room), birth weight, and birth order 
of the child.
Statistical analyses. We investigated 
incidence of childhood cancer by total dose 
rate using time to event analyses with age as 
the underlying time scale. Follow-up time 
began at the first census in which a child 
was recorded (entry time) and ended on the 
earliest of following events: diagnosis, death, 
emigration, the child’s 16th birthday, admin-
istrative censoring on 31 December 2008. 
Exposure was based on residential location at 
census. For a child appearing in both censuses 
but living at a different location in 2000 than 
in 1990, the 1990 exposure was updated in 
1995 or 2000 depending on whether or not 
the child lived at the new location 5 years 
before census 2000 (information from census 
questionnaire). Total dose rate was catego-
rized into regular intervals of 50 nSv/hr with 
subsequent regrouping such that no interval 
contained < 1% of the census populations. 
This resulted in the following categorization: 
< 100 nSv/hr, 100 to < 150, 150 to < 200, 
≥ 200 nSv/hr. We estimated hazard ratios 
(HR) for different exposure categories using 
Cox proportional hazards models. All models 
were adjusted for sex and birth year, and in 
separate models we adjusted for the other 
potential confounders. We also ran trend 
analyses using a linear exposure term. To 
explore potential effects of misclassification 
due to residential mobility, we restricted time-
to-event analyses to children who had a stable 
place of residence up to entry into the cohort, 
defined as those reporting at entry to have had 
the same residence 5 years earlier or, if these 
data were missing (e.g., for children < 5 years 
of age at census), reporting to have lived in the 
same municipality at birth.
We repeated the trend analyses using 
cumulative dose instead of dose rate. 
Cumulative dose was calculated by inte-
grating dose rate over time since birth. To 
conduct these analyses, we created a nested 
case–control data set by randomly sampling 
100 controls per case from among those at risk 
at the time of the case’s failure. We then calcu-
lated cumulative doses and fitted conditional 
logistic regression models conditioning on 
case–controls sets. This procedure is asymptot-
ically equivalent to Cox proportional hazards 
regression using the full cohort (Goldstein 
and Langholz 1992). All analyses were done 
using Stata version 12.1 (StataCorp, College 
Station, TX, USA).
Results
Characteristics of the study population. Of 
3,502 eligible patients in the SCCR who were 
diagnosed between the census in 1990 and 
the end of 2008, 1,782 could be included in 
time-to-event analyses, and of these 1,311 
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belonged to the subcohort of children with 
stable place of residence (Figure 1). The 
distribution of diagnoses among eligible and 
included cases is shown in Supplemental 
Material, Table S1. Because included cases 
were required to be without diagnosis at 
census, they tended to be older at diagnosis 
and hence included slightly fewer leukemia 
and more lymphoma and CNS cases 
compared with all eligible cases.
The SNC included 2,129,264 children 
< 16 years of age at census. Of these, 34,371 
were excluded due to uncertain residence and 
1,233 did not contribute person time (mostly 
because they were linked to an SCCR case 
diagnosed before census) leaving 2,093,660 
(98.3%) for time-to-event analyses. These 
children had a mean age of 7.0 years at entry 
into the cohort, that is, the first census they 
were registered in. They were followed-up 
for a mean of 7.7 years and accrued 16.1 
million person-years at risk. Follow-up 
time ended due to emigration or death in 
47,119 children (2.6% of those included). 
At child’s entry into the cohort, the mean 
dose rate of external background radia-
tion was 109 nSv/hr (median, 103 nSv/hr; 
range, 55–383 nSv/hr; interquartile range, 
95–112 nSv/hr). On average, natural 
terrestrial radiation contributed 54 nSv/hr, 
cosmic radiation 45 nSv/hr, and artificial 
terrestrial radiation 8 nSV/hr. In terms of 
exposure variability, natural terrestrial 
radiation is most relevant (see Supplemental 
Material, Figure S1). Table 1 reports other 
characteristics of the study population at 
Figure 1. Flow chart of childhood cancer cases 
included in analyses.
Swiss Childhood Cancer
Registry (SCCR)
1,790 patients linked to the
Swiss National Cohort
1,782 patients included in
time to event analysis
1,311 patients included in
time to event analysis in
subpopulation with stable
place of residence
3,502 eligible patients
diagnosed 1990–2008
1,288 patients
diagnosed before or
born after census
471 patients known
to have relocated
between birth and
census
424 unlinked
patients
8 excluded
4 with uncertain place of
residence at census
4 with recorded emigration
before diagnosis
2,214 potential incident
cases
Table 1. Characteristics of study population by exposure to external background radiation.
Characteristic
Exposure category [n (%)]
p-Valuea
< 100 nSv/hr 
n = 806,450 
(100.0%)
100 to 
< 150 nSv/hr 
n = 1,146,470 
(100.0%)
150 to 
< 200 nSv/hr 
n = 119,245 
(100.0%)
≥ 200 nSv/hr 
n = 21,495 
(100.0%)
Sex
Male 413,816 (51.3) 587,551 (51.2) 61,002 (51.2) 10,980 (51.1) 0.620
Female 392,634 (48.7) 558,919 (48.8) 58,243 (48.8) 10,515 (48.9)
Year of birth
1974–1979 143,378 (17.8) 206,716 (18.0) 22,720 (19.1) 3,884 (18.1) < 0.001
1980–1984 147,055 (18.2) 210,097 (18.3) 21,658 (18.2) 4,072 (18.9)
1985–1989 171,858 (21.3) 247,084 (21.6) 24,959 (20.9) 4,636 (21.6)
1990–1994 167,075 (20.7) 234,456 (20.5) 24,091 (20.2) 4,398 (20.5)
1995–2000 177,084 (22.0) 248,117 (21.6) 25,817 (21.7) 4,505 (21.0)
Degree of urbanization
Urban 142,366 (17.7) 335,881 (29.3) 22,915 (19.2) 913 (4.2) < 0.001
Peri-urban 366,564 (45.5) 526,711 (45.9) 52,251 (43.8) 7,214 (33.6)
Rural 297,520 (36.9) 283,878 (24.8) 44,079 (37.0) 13,368 (62.2)
Swiss-SEP index
1st quintile (low SEP) 210,686 (26.1) 297,632 (26.0) 56,522 (47.4) 11,423 (53.1) < 0.001
2nd quintile 172,663 (21.4) 227,926 (19.9) 30,711 (25.8) 5,006 (23.3)
3rd quintile 161,461 (20.0) 214,197 (18.7) 18,456 (15.5) 3,098 (14.4)
4th quintile 146,832 (18.2) 209,000 (18.2) 10,398 (8.7) 1,568 (7.3)
5th quintile (high SEP) 112,837 (14.0) 194,929 (17.0) 2,687 (2.3) 351 (1.6)
Missing 1,971 (0.2) 2,786 (0.2) 471 (0.4) 49 (0.2)
Education level of head of household
Compulsory or less 138,987 (17.2) 210,295 (18.3) 24,486 (20.5) 3,502 (16.3) < 0.001
Secondary level 407,213 (50.5) 555,474 (48.5) 64,151 (53.8) 13,056 (60.7)
Tertiary level 235,179 (29.2) 341,226 (29.8) 27,434 (23.0) 4,390 (20.4)
Not known 25,071 (3.1) 39,475 (3.4) 3,174 (2.7) 547 (2.5)
Persons per room (tertiles)
< 0.82 297,857 (36.9) 405,454 (35.4) 39,882 (33.4) 7,372 (34.3) < 0.001
0.82 to < 1.08 296,570 (36.8) 417,782 (36.4) 44,575 (37.4) 7,929 (36.9)
≥ 1.08 212,023 (26.3) 323,234 (28.2) 34,788 (29.2) 6,194 (28.8)
Birth weight [g (tertiles)]
< 3,152 152,649 (18.9) 216,703 (18.9) 24,864 (20.9) 4,945 (23.0) < 0.001
3,152 to < 3,541 152,019 (18.9) 209,712 (18.3) 22,582 (18.9) 4,406 (20.5)
≥ 3,541 156,445 (19.4) 212,081 (18.5) 20,558 (17.2) 3,844 (17.9)
Missing 345,337 (42.8) 507,974 (44.3) 51,241 (43.0) 8,300 (38.6)
Birth sequence
1st 193,045 (23.9) 272,626 (23.8) 29,287 (24.6) 5,581 (26.0) < 0.001
2nd 168,655 (20.9) 233,509 (20.4) 25,130 (21.1) 4,825 (22.4)
3rd or later 85,261 (10.6) 109,151 (9.5) 11,207 (9.4) 2,343 (10.9)
Missing 359,489 (44.6) 531,184 (46.3) 53,621 (45.0) 8,746 (40.7)
Distance to nearest highway (m)
< 100 10,756 (1.3) 16,325 (1.4) 1,317 (1.1) 397 (1.8) < 0.001
100 to < 250 28,945 (3.6) 47,372 (4.1) 5,318 (4.5) 1,072 (5.0)
250 to < 500 62,115 (7.7) 97,023 (8.5) 11,792 (9.9) 1,578 (7.3)
≥ 500 704,634 (87.4) 985,750 (86.0) 100,818 (84.5) 18,448 (85.8)
Distance to high-voltage power line (m)
< 100 6,066 (0.8) 7,198 (0.6) 2,203 (1.8) 588 (2.7) < 0.001
100 to < 250 17,212 (2.1) 19,262 (1.7) 5,536 (4.6) 2,183 (10.2)
250 to < 500 41,979 (5.2) 52,866 (4.6) 11,736 (9.8) 3,281 (15.3)
≥ 500 741,193 (91.9) 1,067,144 (93.1) 99,770 (83.7) 15,443 (71.8)
EMF from broadcast transmitters (V/m)b
< 0.05 719,804 (89.3) 953,221 (83.1) 87,381 (73.3) 18,990 (88.3) < 0.001
0.05 to < 0.2 67,901 (8.4) 142,217 (12.4) 19,705 (16.5) 1,019 (4.7)
≥ 0.2 17,390 (2.2) 48,744 (4.3) 11,900 (10.0) 1,454 (6.8)
Missing 1,355 (0.2) 2,288 (0.2) 259 (0.2) 32 (0.1)
Abbreviations: SEP, socioeconomic position; EMF, electromagnetic fields.
aFrom chi-square tests. bModeled field strength from radio and TV transmitters.
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entry into the cohort according to catego-
ries of total external background radiation. 
Compared with the least exposed group, 
highly exposed children tended to live in 
more rural areas and in neighborhoods of 
lower SEP. For instance, 53% of children 
exposed to a dose rate of ≥ 200 nSv/hr 
belonged to the lowest SEP quintile compared 
with 26% of those exposed to < 100 nSv/hr. 
Children with higher exposure also tended to 
be more exposed to highways and electromag-
netic fields from high voltage power lines and 
broadcast transmitters.
Association between childhood cancer 
and dose rate. Tables 2 and 3 and Figure 2 
show results of analyses using dose rate as 
exposure. We found a markedly increased 
risk among children exposed to a dose rate 
≥ 200 nSv/hr compared with those exposed 
to < 100 nSv/hr for any cancer [hazard ratio 
(HR) = 1.64; 95% confidence interval (CI): 
1.13, 2.37], leukemia (HR = 2.04; 95% CI: 
1.11, 3.74), ALL (HR = 2.12; 95% CI: 
1.09, 4.16), and CNS tumors (HR = 1.99; 
95% CI: 0.98, 4.05) (Table 2). For interme-
diate exposure levels, HRs tended to be close 
to 1. Adjusting for potential confounders did 
not materially alter results (see Supplemental 
Material, Figure S2). In trend analyses using 
a linear exposure term, HRs per increase of 
100 nSv/hr in dose rate were between 1.2 
and 1.4 for all diagnostic groups except 
lymphoma, where it was close to 1. The 
lower confidence limit exceeded 1 only for 
all cancers (HR = 1.27; 95% CI: 1.06, 1.52 
per 100 nSv/hr) (Table 3, Figure 2). 
When we restricted analyses to children 
with stable residence before entry into the 
cohort (66.5% of the entire cohort), results 
remained similar with somewhat larger effect 
estimates (Table 3; see also Supplemental 
Material, Table S2).
Trend analyses using cumulative dose. 
Calculated cumulative dose had a mean of 
9.06 mSv (median, 9.12 mSv; range, 0.03–
49.4 mSv; interquartile range, 5.55–12.1 mSv) 
and, as expected, correlated strongly with 
age (see Supplemental Material, Table S3). 
Trend analyses using cumulative dose 
showed a similar pattern as for dose rate with 
stronger evidence of a trend for all cancers 
(HR = 1.028; 95% CI: 1.008, 1.048 per mSv 
cumulative dose), leukemia (HR = 1.036; 
95% CI: 0.997, 1.077), and CNS tumors 
(HR = 1.042; 95% CI: 1.002, 1.084) 
(Table 4). Restricting to the subcohort with 
stable place of residence before census again 
resulted in larger effect estimates, particularly 
for CNS tumors (HR = 1.060; 95% CI: 
1.015, 1.106 per mSv) (Table 4).
Discussion
This nationwide census-based cohort study in 
Switzerland found evidence of an increased 
risk of cancer among children exposed to 
external dose rates of background ionizing 
radiation of ≥ 200 nSv/hr compared with 
those exposed to < 100 nSv/hr. Trend 
analyses showed an increasing risk with 
cumulative dose received since birth for all 
cancers taken together, and for leukemia and 
CNS tumors.
Although the effects of acute exposure 
to moderate or high doses (> 100 mSv) of 
ionizing radiation on the risk of childhood 
cancer have been clearly demonstrated, the 
evidence for protracted exposure to low-dose 
radiation is still scarce (Wakeford 2013). 
Studies from high-risk groups, including 
atomic bomb survivors and groups exposed 
to therapeutic radiation, report relative risks 
in the order of about 5–8 and 2–5 per Sv 
for leukemia and CNS tumors, respectively, 
among subjects exposed at < 20 years of age 
(UNSCEAR 2013). For leukemia, estimated 
relative risks exceed 50 per Sv shortly after 
exposure among those exposed in early 
life (UNSCEAR 2013; Wakeford 2013). 
Extrapolating from models calibrated to 
risks observed in atomic bomb survivors, the 
excess fraction of childhood leukemia cases 
due to natural background radiation has 
been estimated to be up to about 20% in 
France (Laurent et al. 2013) and the United 
Kingdom (Little et al. 2009). However, 
there are great uncertainties attached to 
such estimates.
A recent register-based case–control 
study from the United Kingdom including 
27,447 cases (of whom 9,058 had leukemia 
and 6,585 had CNS tumors) and 36,793 
matched controls found a relative risk of 
1.03 (95% CI: 1.00, 1.07) for all child-
hood cancer, 1.09 (95% CI: 1.02, 1.17) 
for leukemia, 1.10 (95% CI: 1.02, 1.19) 
for ALL, 1.01 (95% CI: 0.93, 1.09) for 
Table 2. Association between childhood cancer and dose rate of external background radiation in the 
Swiss National Cohort.
Outcome Dose rate (nSv/hr) Cases (n) IRa HR (95% CI)b
All cancers < 100 659 10.56 1.00 (reference)
100 to < 150 982 11.16 1.06 (0.96, 1.17)
150 to < 200 112 12.32 1.17 (0.96, 1.43)
≥ 200 29 17.22 1.64 (1.13, 2.37)
Leukemia < 100 201 3.22 1.00 (reference)
100 to < 150 288 3.27 1.02 (0.85, 1.22)
150 to < 200 30 3.30 1.03 (0.70, 1.51)
≥ 200 11 6.53 2.04 (1.11, 3.74)
ALL < 100 158 2.53 1.00 (reference)
100 to < 150 225 2.56 1.01 (0.82, 1.24)
150 to < 200 24 2.64 1.05 (0.68, 1.61)
≥ 200 9 5.34 2.12 (1.09, 4.16)
Lymphoma < 100 122 1.96 1.00 (reference)
100 to < 150 186 2.11 1.08 (0.86, 1.36)
150 to < 200 17 1.87 0.96 (0.58, 1.59)
≥ 200 3 1.78 0.91 (0.29, 2.86)
CNS tumors < 100 150 2.40 1.00 (reference)
100 to < 150 239 2.72 1.13 (0.92, 1.39)
150 to < 200 26 2.86 1.19 (0.79, 1.81)
≥ 200 8 4.75 1.99 (0.98, 4.05)
Other malignant tumors < 100 186 2.98 1.00 (reference)
100 to < 150 269 3.06 1.03 (0.85, 1.24)
150 to < 200 39 4.29 1.44 (1.02, 2.04)
≥ 200 7 4.16 1.39 (0.66, 2.97)
Abbreviations: ALL, acute lymphoblastic leukemia; CNS, central nervous system; HR, hazard ratio; IR, incidence rate.
aPer 100,000 person-years at risk. bFrom Cox proportional hazards models adjusting for sex and birth year. 
Table 3. Hazard ratios for childhood cancer per 100 nSv/hr dose rate of external radiation in the Swiss 
National Cohort.
Outcome
Entire cohort
Subcohort with stable place  
of residence before entrya
HR (95% CI)b p-Value HR (95% CI)b p-Value
All cancers 1.27 (1.06, 1.52) 0.011 1.33 (1.08, 1.62) 0.006
Leukemia 1.25 (0.90, 1.75) 0.186 1.31 (0.90, 1.92) 0.159
ALL 1.23 (0.84, 1.81) 0.278 1.31 (0.86, 2.01) 0.205
Lymphoma 1.06 (0.68, 1.67) 0.788 1.16 (0.70, 1.92) 0.558
CNS tumors 1.32 (0.91, 1.91) 0.139 1.42 (0.96, 2.12) 0.081
Other malignant tumors 1.37 (0.98, 1.91) 0.064 1.36 (0.93, 1.98) 0.110
Abbreviations: ALL, acute lymphoblastic leukemia; CNS, central nervous system; HR, hazard ratio.
aChildren with same residence 5 years before entry into the cohort or, if this information was lacking, lived in the 
same municipality at birth. bFrom Cox proportional hazards models using a linear exposure term adjusting for sex and 
birth year.
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lymphoma, and 1.02 (95% CI: 0.96, 1.08) 
for CNS tumors for each milligray increase 
in cumulative indoor gamma-ray exposure 
since birth (Kendall et al. 2013). Given the 
rarity of childhood cancer, the hazard ratios 
per millisievert increase in cumulative dose 
of outdoor radiation found in our study 
(Table 4) can be interpreted as risk ratios 
(Symons and Moore 2002). Assuming a 
20% reduction of doses due to the shielding 
effect of buildings (UNSCEAR 2000), an 
estimated difference of 1 mSv cumula-
tive dose in our data relates to a difference 
indoors of 0.8 mSv, and the results in the 
first column of Table 4 translate to relative 
risks of 1.03 (95% CI: 1.01, 1.06) for all 
childhood cancers, 1.05 (95% CI: 1.00, 1.10) 
for leukemia, 1.05 (95% CI: 0.99, 1.11) 
for ALL, 1.01 (95% CI: 0.96, 1.07) for 
lymphoma, and 1.05 (95% CI: 1.00, 1.11) 
for CNS tumors. Compared to the UK study, 
our point estimates are smaller for leukemia 
and larger for CNS tumors. However, the 
wide overlap of confidence intervals for 
corresponding outcomes demonstrates good 
agreement between the studies. The effect 
estimates observed in the population with 
stable residence before entry into the cohort 
(Table 4) suggest that failure to account for 
residential mobility results in a downward 
bias and that relative risks in both studies 
were underestimated. Somewhat surpris-
ingly, our confidence intervals are narrower 
despite the much smaller number of cases 
included in the study. This could have several 
reasons: For a given number of cases, a cohort 
study such as ours has larger statistical power 
than a case–control study with only a single 
control per case (Little et al. 2010); both the 
case–control pairs in the UK study and the 
risk sets in our study were age-matched; and, 
conditional on age, variability of cumulative 
exposure was considerably larger in our study 
[compare Supplemental Material, Table S3, 
with Table S7 in Kendall et al. (2013)]; 
furthermore, the UK study assessed exposures 
with a lower spatial resolution, and, conse-
quently, almost half of the cases shared the 
same exposure level as their controls.
Few other studies have used individual 
data to investigate a potential link between 
childhood cancer and radiation from 
natural gamma or cosmic rays (Axelson 
et al. 2002; UK Childhood Cancer Study 
Investigators 2002b) (see Supplemental 
Material, Table S4). The UK Childhood 
Cancer Study—a case–control study that 
used gamma dose rates (including the 
cosmic component of penetrating radia-
tion) measured in children’s homes at the 
time of diagnosis—found no evidence of an 
association for leukemia. As in our analysis, 
effect estimates for CNS tumors were elevated 
in the highest exposure categories, but 
confidence intervals were wide and included 
one. A case–control study from Sweden 
reported an odds ratio of 1.4 (95% CI: 
1.0, 2.0) for ALL among subjects < 20 years 
of age, comparing those living in buildings 
made of alum shale concrete with those living 
in other houses (Axelson et al. 2002). Overall, 
studies using individual data suggest an 
increasing risk for ALL with cumulative dose 
of natural gamma radiation (see Supplemental 
Material, Table S4). In contrast to this, an 
investigation in high background radiation 
Figure 2. Hazard ratios for cancer by dose rate of external ionizing radiation among children < 16 years of 
age in the Swiss National Cohort. Results from Cox proportional hazards models adjusting for sex and birth 
year using a categorized exposure [points and bars (95% CIs) placed along the x-axis at mean dose rates 
within categories; categories delineated by vertical lines] and a linear exposure term (blue line). Dose 
rates < 100 nSv/hr are the reference category. 
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areas in China and India found no indica-
tion of increased risks of childhood leukemia 
(Akiba et al. 2002).
We did not adjust for domestic radon 
exposure because this information was avail-
able only for the 2000 census, and our recent 
study on domestic radon and childhood 
cancer found no evidence of an association in 
the SNC (Hauri et al. 2013). The UK record-
based case–control study by Kendall et al. 
and the UK Childhood Cancer Study also 
found little indication of an increased risk 
of childhood cancers due to radon (Kendall 
et al. 2013; UK Childhood Cancer Study 
Investigators 2002a). However, a Danish 
record-based case–control study and most 
ecologic studies reported positive associations 
between childhood leukemia and domestic 
radon (Raaschou-Nielsen 2008; Raaschou-
Nielsen et al. 2008; Tong et al. 2012).
Exposure assessment in our study was 
based on a geographic model rather than on 
actual measurements at children’s homes. 
Although the model was based on a dense 
net of measurements covering the entire 
country, methods of interpolation and cali-
bration, measurement error, and the neglect 
of exposure variability due to natural factors 
such as snow cover or sun activity are likely 
to have caused some exposure misclassifica-
tion. Calculated doses were based on outdoor 
dose rates, although children spend most of 
their time indoors. Unfortunately we did not 
have address histories for the entire popula-
tion and could therefore not fully account 
for residential mobility in our calculation of 
cumulative dose. However, for some children 
(21%) residential locations were known at 
two time points. Outcome assessment was 
based on probabilistic record linkage between 
the SCCR and SNC and is likely to have 
resulted in some misclassification of the 
outcomes. Based on linkage results, we judge 
that at least 93% of the linked SCCR–SNC 
pairs represent true matches. These either had 
residential locations matching to within 50 m 
combined with perfect matches on date of 
birth, sex, and municipality of residence at 
birth or had more convincing similarities. 
Assuming that half of the remaining pairs 
are false matches, < 4% of those classified as 
having cancer were false positives. Conversely, 
> 400 potentially incident cases were not 
linked to the SNC, likely resulting in false 
negatives. But we found no indication that 
these differed from linked cases in radiation 
exposure, suggesting that the risk of bias due 
to linkage errors was small.
Major strengths of our study are its 
cohort design and the use of nationwide 
routine data. The cohort design maximizes 
statistical power for a given number of cases 
and accounts for lost to follow-up by migra-
tion or death. Assessment of both exposures 
and outcomes were based on routine data 
of nationwide coverage essentially elimi-
nating the risk of selection bias. Our study 
was able to include a wide range of poten-
tial confounding factors. Furthermore, our 
study was based on a  relatively wide range of 
exposure levels. 
It is plausible that the observed asso-
ciations between background radiation 
and childhood cancer reflect a causal rela-
tionship: Ionizing radiation is known to 
cause childhood cancer at high doses and 
dose rates. Associations were stronger for 
outcomes previously linked to radiation, 
such as leukemia and CNS tumors, although 
no evidence of an association was found 
for lymphoma where such links have been 
less demonstrable (UNSCEAR 2006). Our 
findings were little affected by adjustments for 
a number of potentially confounding factors. 
We found evidence of a dose response, and 
this evidence was strongest in a subcohort of 
children with stable residence before entry 
into the cohort, that is, with less exposure 
misclassification due to residential mobility. 
We cannot, however, exclude biases due to 
inaccurate exposure measurement.
In conclusion, our study suggests that 
background radiation may contribute to the 
risk of cancer in children. Results suggest 
that risks for leukemia and CNS tumors are 
similarly affected. Future research in this 
field could greatly benefit from improved 
exposure assessment.
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